CAD-1883

· Cadent Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAD-1883, covering 2021-07-09 to 2021-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate CAD-1883 in Essential Tremor [Phase 2]